Weight gain from novel antipsychotic drugs: need for action
- 1 July 2000
- journal article
- review article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 22 (4) , 224-235
- https://doi.org/10.1016/s0163-8343(00)00081-5
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Obesity: a time bomb to be defusedThe Lancet, 1998
- Overweight and obesity in the United States: prevalence and trends, 1960–1994International Journal of Obesity, 1997
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Absorption of Vitamins A and E in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996
- A Double‐Blind Randomized Placebo‐Controlled Trial of SibutramineObesity Research, 1996
- Early Detection and Intervention in Schizophrenia: ResearchSchizophrenia Bulletin, 1996
- Sibutramine: A Novel New Agent for Obesity TreatmentObesity Research, 1995
- Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia.Neuropsychology, 1995
- Effect of Degree of Weight Loss on Health BenefitsObesity Research, 1995
- Physical Activity and Long‐Term Maintenance of Weight LossObesity Research, 1994
- Syndrome XHormone Research, 1993